LDC000067( LDC000067 | LDC-000067 | LDC 000067 )

Catalog No. M17138 CAS No. 1073485-20-7

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

LDC000067
Note

Research use only, not for human use.
Brief Description

LDC000067 is a highly specific and selective CDK9 inhibitor with an IC50 value of 44±10 nM.
Description

LDC000067 is a potent and selective CDK9 inhibitor. LDC000067 inhibited in vitro transcription in an ATP-competitive and dose-dependent manner. Gene expression profiling of cells treated with LDC000067 demonstrated a selective reduction of short-lived mRNAs, including important regulators of proliferation and apoptosis. Analysis of de novo RNA synthesis suggested a wide ranging positive role of CDK9. At the molecular and cellular level, LDC000067 reproduced effects characteristic of CDK9 inhibition such as enhanced pausing of RNA polymerase II on genes and, most importantly, induction of apoptosis in cancer cells.
In Vitro

The selectivity of LDC000067 for CDK9 over other CDKs exceeds that of the known inhibitors flavopiridol and DRB. LDC000067 displayed 55/125/210/ >227/ >227-fold selectivity for CDK9 versus CDK2/1/4/6/7. LDC000067 inhibits in vitro transcription in an ATP-competitive and dose-dependent manner. Gene expression profiling of cells treated with LDC000067 demonstrates a selective reduction of short-lived mRNAs, including important regulators of proliferation and apoptosis.
In Vivo

——
Synonyms

LDC000067 | LDC-000067 | LDC 000067
Pathway

Others
Target

Other Targets
Recptor

CDK1| CDK2| CDK4| CDK6| CDK9
Research Area

Cancer
Indication

——

CAS Number

1073485-20-7
Formula Weight

370.43
Molecular Formula

C18H18N4O3S
Purity

>98% (HPLC)
Solubility

DMSO : ≥ 47 mg/mL 126.88 mM
SMILES

COc1ccccc1c1cc(ncn1)Nc1cccc(c1)CS(=O)(=O)N
Chemical Name

6-(6-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio)quinoline

1. Albert TK, et al. Br J Pharmacol. 2014, 171(1), 55-68.

Calculator

molnova catalog